Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing. Prof. N.K. Jain is an internationally renowned academician and researcher and a senior professor in India who superannuated in June 2014 after rendering more than 40 years of dedicated and distinguished service as a teacher and 25 years as full professor. Prof. Jain is the author of two dozen celebrated books in pharmaceutical sciences in India and has contributed several chapters in national and international books. He has to his credit over 480 publications in reputed pharmaceutical Journals and has supervised 55 PhD and 141 M. Pharm. candidates. He has been a reviewer for several international and national research journals. Professor Jain’s current research interests include various aspects of controlled, novel and targeted drug delivery; nanotechnology and nanomedicine and he is globally known for his excellent research in the field of hydrotropic solubilization, resealed erythrocytes-based drug delivery and dendrimer drug delivery. Currently he is exploring the pharmaceutical potential of Carbon Nanotubes and Quantum Dots. Recently he has also contributed two chapters on international books.

• 1. Nanostructures and their associated challenges for drug delivery2. Characterization techniques of hybrid drug delivery systems3. Hybrid drug nanocrystals for drug delivery4. Hybrid nanogel systems for drug delivery5. Polymer-lipid hybrid nanostructures for drug delivery6. Hybrid chitosan-based drug delivery systems for drug delivery7. Hybrid polymer–metal composites for drug delivery8. Hybrid protein-inorganic nanoparticles for drug delivery9. Silica based hybrid systems for drug delivery10. Dendrimer nanohybrid systems for drug delivery11. Bioactive hybrid nanowires for drug delivery12. Hybrid carbon-based materials for drug delivery13. Quantum dots hybrid systems for drug delivery14. Strengths, limitations and regulatory aspects of hybrid drug delivery systems15. Recent advances and future prospective of hybrid drug delivery systems